World leading expertise in developing true generics for injectable slow release drugs and proprietary high-yield protein expression technology.
Pioneering high demand complex generics
Introducing the world's first slow release injectable generics.
Constantly outperforming industry standards by developing biosimilars. with next generation technology.
Complex generics made affordable
We enable global health equality by bringing affordable drugs to treat underserved people suffering from critical diseases.